BCR-ABL1 Transcript ≤10% IS an Early Molecular Response Predictor of Treatment-Free Remission Eligibility in Chronic Myeloid Leukemia.
| Published in: | Clinical Lymphoma, Myeloma & Leukemia Vol. 26; no. 7; pp. 447 - 456 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Published: |
Elsevier B.V.
Jul2026
|
| Online Access: | View this record in EBSCOhost |
| Description not available. |